FDA approvalconf 0.99

rezipres — FDA approval

$ETON · Eton Pharmaceuticals, Inc. · clinically important hypotension occurring in the setting of anesthesia

Event date

June 15, 2021

1817 days ago

Sponsor runway

cash-flow +

$19.7M liquid

Evidence

“On June 15, 2021, Eton Pharmaceuticals, Inc. issued a press release announcing the U.S. Food and Drug Administration has approved Rezipres® (ephedrine hydrochloride injection) for the treatment of clinically important hypotension occurring in the setting of anesthesia.”

Source: 8-K filed 2021-06-15View on EDGAR ↗0001493152-21-014410

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)

Ticker	Drug	Date	Outcome
$INCY	zynyz	2026-05-18	success
$INCY	jakafi xr	2026-05-01	success
$AXSM	auvelity	2026-04-30	success
$INCY	zynyz	2026-03-30	success
$BIIB	spinraza	2026-03-27	success
$CORT	lifyorli	2026-03-25	success
$RYTM	imcivree	2026-03-19	success
$ASND	yuviwel	2026-02-27	success
$BMRN	palynziq	2026-02-27	success
$ETON	desmoda	2026-02-25	success

Recent insider activity· ±90 days

3 insiders · 3 buys · 14 sells

Buy

2021-08-20

BRYNJELSEN SEAN

President & CEO

10,000 @ $4.32$43K

Buy

2021-08-20

Troutman William Wilson

CFO and Secretary

5,000 @ $4.43$22K

Sell

2021-08-06

Opaleye Management Inc.

10%+ Owner

15,000 @ $5.84$88K

Sell

2021-08-06

Opaleye Management Inc.

10%+ Owner

330,000 @ $5.84$1.93M

Sell

2021-08-05

Opaleye Management Inc.

10%+ Owner

150,000 @ $5.85$878K

Sell

2021-08-05

Opaleye Management Inc.

10%+ Owner

5,500 @ $5.85$32K

Sell

2021-08-04

Opaleye Management Inc.

10%+ Owner

100,000 @ $5.75$575K

Sell

2021-08-04

Opaleye Management Inc.

10%+ Owner

4,000 @ $5.75$23K

Sell

2021-06-15

Opaleye Management Inc.

10%+ Owner

4,000 @ $8.07$32K

Sell

2021-06-15

Opaleye Management Inc.

10%+ Owner

101,000 @ $8.07$815K

Buy

2021-06-03

BRYNJELSEN SEAN

President & CEO

5,000 @ $5.96$30K

Sell

2021-05-27

Opaleye Management Inc.

10%+ Owner

121,400 @ $8.49$1.03M

Sell

2021-05-27

Opaleye Management Inc.

10%+ Owner

4,600 @ $8.49$39K

Sell

2021-05-26

Opaleye Management Inc.

10%+ Owner

2,800 @ $8.57$24K

Sell

2021-05-26

Opaleye Management Inc.

10%+ Owner

65,500 @ $8.57$561K

Sell

2021-05-25

Opaleye Management Inc.

10%+ Owner

2,000 @ $8.53$17K

Sell

2021-05-25

Opaleye Management Inc.

10%+ Owner

46,000 @ $8.53$392K

Date	Insider	Action	Shares	Price	Value
2021-08-20	BRYNJELSEN SEANPresident & CEO	Buy	10,000	$4.32	$43K
2021-08-20	Troutman William WilsonCFO and Secretary	Buy	5,000	$4.43	$22K
2021-08-06	Opaleye Management Inc.10%+ Owner	Sell	15,000	$5.84	$88K
2021-08-06	Opaleye Management Inc.10%+ Owner	Sell	330,000	$5.84	$1.93M
2021-08-05	Opaleye Management Inc.10%+ Owner	Sell	150,000	$5.85	$878K
2021-08-05	Opaleye Management Inc.10%+ Owner	Sell	5,500	$5.85	$32K
2021-08-04	Opaleye Management Inc.10%+ Owner	Sell	100,000	$5.75	$575K
2021-08-04	Opaleye Management Inc.10%+ Owner	Sell	4,000	$5.75	$23K
2021-06-15	Opaleye Management Inc.10%+ Owner	Sell	4,000	$8.07	$32K
2021-06-15	Opaleye Management Inc.10%+ Owner	Sell	101,000	$8.07	$815K
2021-06-03	BRYNJELSEN SEANPresident & CEO	Buy	5,000	$5.96	$30K
2021-05-27	Opaleye Management Inc.10%+ Owner	Sell	121,400	$8.49	$1.03M
2021-05-27	Opaleye Management Inc.10%+ Owner	Sell	4,600	$8.49	$39K
2021-05-26	Opaleye Management Inc.10%+ Owner	Sell	2,800	$8.57	$24K
2021-05-26	Opaleye Management Inc.10%+ Owner	Sell	65,500	$8.57	$561K
2021-05-25	Opaleye Management Inc.10%+ Owner	Sell	2,000	$8.53	$17K
2021-05-25	Opaleye Management Inc.10%+ Owner	Sell	46,000	$8.53	$392K

← All catalysts for $ETON